Table 3.
Comparison of women with different ovarian malignancies positive for vaginal lysophosphatidic acid and CA125.
| Diagnosis | No. tested | No. (%) positive |
|||
|---|---|---|---|---|---|
| CA125 only | LPA only | Both | Neither | ||
| Endometrioid+/− Clear cell | 6 | 1 (16.6) | 5 (83.3) | 0 | 0 |
| Serous | 6 | 3 (50.0) | 1(16.7) | 2(33.3) | 0 |
| Mucinous | 3 | 1(33.3) | 0 | 1(33.3) | 1(33.3) |
| MMMT | 2 | 2(100) | 0 | 0 | 0 |
| Granulosa | 2 | 0 | 1(50.0) | 0 | 1 (50.0) |
| Other | 2 | 0 | 0 | 1(50.0) | 1 (50.0) |
| Clear cell | 1 | 0 | 0 | 0 | 1(100) |
| Mixed | 1 | 1 (100%) | 0 | 0 | 0 |
Endometrioid +/− Clear cell, endometrioid tumor with and without clear cell components; MMMT, malignant mixed mesoderm tumor (carcinosarcoma); Other, metastatic adrenal, leiomyosarcoma.